FIELD: medicine pharmaceutics.SUBSTANCE: invention refers to a method for preparing fine pharmaceutical compositions of salbutamol. The declared method consists in quick cooling of an initial solution of salbutamol and glycine or salbutamol and lactose monohydrate in a solvent of tetrahydrofuran (THF) and water wherein the THF concentration makes 5-25 wt % by spraying the initial solution into a container with liquid nitrogen. The prepared mixture of solid phases is cleaned from the solvents by ...